Continuous Glucose Monitoring Market Report
First published: 07 October 2024 | Last updated: 25 May 2026 | Report Code: continuous-glucose-monitoring
Continuous Glucose Monitoring Market — USD 5.6 billion in 2023, Growing to USD 13.91B by 2033 at 9.2% CAGR
This report analyzes the Continuous Glucose Monitoring market, presenting insights into market size, segmentation, and trends. It forecasts market developments from 2023 to 2033, covering key players, technological advancements, and regional dynamics critical for stakeholders in the health technology landscape.
Key Takeaways
- Global market value grows from $5.60 Billion in 2023 to $13.91 Billion in 2033 at a 9.2% CAGR.
- Europe is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- North America increases from $1.84 Billion to $4.58 Billion over the forecast period.
- Asia Pacific advances from $1.06 Billion in 2023 to $2.62 Billion by 2033.
- Leading companies include Dexcom, Inc., Abbott Laboratories, Medtronic plc, and Senseonics Holdings, Inc.
Continuous Glucose Monitoring Market Report — Executive Summary
Europe remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The report assesses the Continuous Glucose Monitoring market across product types, technologies, applications, end users, distribution channels and regions. Market growth from $5.60 Billion in 2023 to $13.91 Billion in 2033 at a 9.2% CAGR is supported by rising diabetes management needs, adoption of remote patient monitoring and ongoing device improvements. Europe represents the largest regional market, with notable expansions also in North America and Asia Pacific. Key players such as Dexcom, Inc., Abbott Laboratories, Medtronic plc and Senseonics Holdings, Inc. are shaping competition through product innovation and expanded distribution. The analysis covers segment-level performance, regional trends and regulatory and reimbursement influences that affect adoption and pricing dynamics. Findings are intended to inform strategic planning, partnership assessment and commercial prioritization for stakeholders across the value chain.
Key Growth Drivers
- Increasing prevalence of diabetes and related conditions fueling demand for continuous monitoring solutions.
- Advances in sensor and transmitter technologies improving accuracy and user convenience.
- Rising adoption of remote patient monitoring and telehealth supporting CGM integration.
- Expanding distribution channels, including online platforms, enhancing patient access.
- Investment by established medical device companies driving product development and commercialization.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $5.60 Billion |
| CAGR (2023-2033) | 9.2% |
| 2033 Market Size | $13.91 Billion |
| Top Companies | Dexcom, Inc., Abbott Laboratories, Medtronic plc, Senseonics Holdings, Inc. |
| Published Date | 07 October 2024 |
| Last Modified Date | 25 May 2026 |
Continuous Glucose Monitoring Market Overview
Customize Continuous Glucose Monitoring Market Report market research report
- ✔ Get in-depth analysis of Continuous Glucose Monitoring market size, growth, and forecasts.
- ✔ Understand Continuous Glucose Monitoring's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Continuous Glucose Monitoring
What is the Market Size & CAGR of Continuous Glucose Monitoring Market Report market in 2023?
Continuous Glucose Monitoring Industry Analysis
Continuous Glucose Monitoring Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Continuous Glucose Monitoring Market Report Market Analysis Report by Region
Europe Continuous Glucose Monitoring Market Report:
Europe is largest regional market, rising from $1.9 Billion in 2023 to $4.72 Billion in 2033. 9 Billion in 2023 to $4.72 Billion in 2033 and is identified as the largest regional market. Growth is supported by healthcare investments, patient adoption of CGM for diabetes management, and ongoing product availability from leading firms.Asia Pacific Continuous Glucose Monitoring Market Report:
Asia Pacific grows from $1.06 Billion in 2023 to $2.62 Billion in 2033. Growth stems from rising awareness of diabetes care, expanding distribution channels, and increased acceptance of remote monitoring solutions.North America Continuous Glucose Monitoring Market Report:
North America grows from $1.84 Billion in 2023 to $4.58 Billion in 2033. Regional expansion reflects strong clinical adoption, payer and provider interest in continuous monitoring, and technology deployment by major device manufacturers.South America Continuous Glucose Monitoring Market Report:
Latin America grows from $0.02 Billion in 2023 to $0.05 Billion in 2033. Market activity is influenced by gradual technology adoption, improvements in healthcare access, and expanding channel presence.Middle East & Africa Continuous Glucose Monitoring Market Report:
Middle East and Africa grows from $0.78 Billion in 2023 to $1.95 Billion in 2033. Regional drivers include increasing chronic disease burden, investments in healthcare infrastructure, and growing interest in connected monitoring devices.Tell us your focus area and get a customized research report.
Research Methodology
Continuous Glucose Monitoring Market Analysis By Product Type
The product type segment includes key components such as glucose sensors (market value growing from USD 3.76 billion to USD 9.33 billion by 2033), transmitters (increasing from USD 1.24 billion to USD 3.08 billion), and receivers (rising from USD 0.60 billion to USD 1.50 billion). The dominance of glucose sensors highlights their vital role in accurate glucose monitoring, while transmitters and receivers facilitate essential data communication.
Continuous Glucose Monitoring Market Analysis By Application
The application segment encompasses diabetes management, gestational diabetes, and sports nutrition, with diabetes management expected to grow from USD 3.76 billion in 2023 to USD 9.33 billion by 2033, capturing around 67.08% market share. This segment will continue to drive innovation and demand for CGMs as healthcare focuses on chronic disease management.
Continuous Glucose Monitoring Market Analysis By End User
Homecare settings are projected to maintain their significant lead, with market values moving from USD 3.76 billion in 2023 to USD 9.33 billion by 2033. Hospitals are also notable, growing from USD 1.24 billion to USD 3.08 billion. Growth in hospitals often reflects advancements in acute care facilities and emergency response capabilities.
Continuous Glucose Monitoring Market Analysis By Distribution Channel
The distribution channels for CGMs include online and offline sales. Online sales are anticipated to grow significantly, increasing from USD 4.86 billion to USD 12.08 billion, indicating a shift toward consumer-direct purchasing models. Offline channels remain relevant, particularly for immediate product need and consultation.
Continuous Glucose Monitoring Market Analysis By Technology
Technological advancements play a critical role, with innovations such as real-time continuous monitoring systems emerging. Real-time CGMs are projected to increase from USD 0.74 billion in 2023 to USD 1.83 billion by 2033, reflecting a growing consumer preference for immediate feedback on glucose levels.
Continuous Glucose Monitoring Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Continuous Glucose Monitoring Industry
Dexcom, Inc.:
Dexcom is a leading developer of continuous glucose monitoring systems, known for innovative solutions like the Dexcom G6, which streamline diabetes management with real-time data and alerts.Abbott Laboratories:
Abbott, with its Freestyle Libre system, revolutionized glucose monitoring by providing an accessible and user-friendly alternative, leading to a significant increase in CGM adoption among diabetes patients.Medtronic plc:
Medtronic is a prominent player in the CGM market, integrating advanced technology into their MiniMed systems, which combine insulin delivery and glucose monitoring for comprehensive diabetes management.Senseonics Holdings, Inc.:
Senseonics specializes in long-term implantable CGM systems, pushing boundaries in the technology with the Eversense product, designed for patients requiring prolonged monitoring solutions.We're grateful to work with incredible clients.
FAQs
What is the market size of the Continuous Glucose Monitoring market in 2023?
The market size in 2023 is $5.60 Billion, as reported in the dataset provided for the 2023 baseline year.
How big will the Continuous Glucose Monitoring market be in 2033?
The market is projected to reach $13.91 Billion by 2033 according to the provided forecast figures.
What is the CAGR for the forecast period?
The forecast period 2023 to 2033 has an exact CAGR of 9.2% as specified in the input data.
Is there a single fastest Growing region in the Continuous Glucose Monitoring Market Report market?
No single fastest-growing region is stated for the Continuous Glucose Monitoring Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are listed as top players?
Top companies named in the input are Dexcom, Inc., Abbott Laboratories, Medtronic plc, and Senseonics Holdings, Inc.
What are the main product types covered in the segmentation?
Product-type subsegments listed include Glucose Sensors, Transmitters, and Receivers as provided in the report data.
How big is the North America market in the report?
North America is reported to grow from $1.84 Billion in 2023 to $4.58 Billion in 2033 based on the supplied regional numbers.
Which distribution channels are specified?
Distribution channels in the input are Online and Offline, each indicated as core subsegments for market access.
What is the role of technology segmentation in the report?
Technology subsegments include Flash Glucose Monitoring and Real-Time Continuous Glucose Monitoring, reflecting device type distinctions in the dataset.
Who contributed to the research methodology?
Research methodology includes primary interviews with industry experts and secondary research from company reports and publications.